Managing hyponatremia: fast or slow? why, when, how, and controversies

Clicks: 27
ID: 326730
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #48 of 228 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 228 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Hyponatremia is the most common electrolyte disorder encountered in clinical practice. Its management is challenging because treatment must balance the risk of cerebral edema in acute hyponatremia against the risk of osmotic demyelination syndrome (ODS) from overly rapid correction of chronic hyponatremia. Recent observational studies have questioned current correction limits, prompting renewed debate regarding optimal management. This narrative review presents a physiology-based approach to the evaluation and treatment of hyponatremia. Acute hyponatremia may cause life-threatening cerebral edema because cerebral adaptation is incomplete, whereas chronic hyponatremia is characterized by the loss of intracellular electrolytes and organic osmolytes that limit brain swelling but increase vulnerability to osmotic injury during correction. Because the duration of hyponatremia is often uncertain, management should be guided primarily by neurological manifestations rather than duration alone. We propose a systematic treatment approach based on neurological severity, the duration of hyponatremia when definitively known, and the patient’s risk of neurological injury, balancing the immediate danger of cerebral edema against the risk of ODS. We critically review the evidence underlying current correction limits and recent observational studies reporting that ODS is uncommon, inconsistently associated with overly rapid correction, and that slower correction has been associated with higher mortality. We conclude that, until higher-quality evidence becomes available, conservative correction limits for management of chronic hyponatremia remain appropriate, with correction not exceeding 10 mmol/L in 24 hours (18 mmol/L in 48 hours) in average-risk patients, targeting a rise of 4–8 mmol/L/day, and 8 mmol/L in 24 hours in patients at high risk for ODS, targeting a rise of 4–6 mmol/L/day.
Reference Key
openalex_W7204457242 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kamel S Kamel, Ziv Harel, Martin Schreiber
Are you one of these authors? Claim your profile
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag288
URL
https://academic.oup.com/ckj/advance-article-pdf/doi/10.1093/ckj/sfag288/70819673/sfag288.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.